Pharmaceutical composition comprising guttiferone F for the treatment of prostate cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9408811
APP PUB NO 20150025155A1
SERIAL NO

14333524

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Prostate cancer is the most commonly diagnosed cancer in males and one of the leading causes of cancer death. Although treatment options have increased for some patients, overall progress has been modest. Thus, there is a great need to develop new treatments. This invention relates to a method for treating cancer comprising using an anti-cancer compound of formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HONG KONG BAPTIST UNIVERSITYKOWLOON TONG KOWLOON HONG KONG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bian, Zhaoxiang Hong Kong, HK 41 7
Chan, Albert Sun Chi Hong Kong, HK 20 12
Chen, Kaixian Hong Kong, HK 52 28
Chen, Shilin Hong Kong, HK 150 1315
Lao, Yuanzhi Hong Kong, HK 10 2
Li, Xin Hong Kong, HK 946 7137
Lu, Aiping Hong Kong, HK 27 7
Tan, Hongsheng Hong Kong, HK 8 1
Wang, Xiaoyu Hong Kong, HK 109 901
Xu, Hongxi Hong Kong, HK 22 4
Yang, Dajian Hong Kong, HK 26 4
Zhang, Hong Hong Kong, HK 882 11808

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 9, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00